Oxervate
Ended Awarded
- Contract number
- 36C24525N0204
- Awardee
-
Dompe U.s. Inc. UEI ECCDSKQAN2J3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $38,614
Award facts
- Contract value 100% obligated
- $38,614.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of Oxervate, an ophthalmic solution used to treat neurotrophic keratitis, to the Department of Veterans Affairs (VA). The contract was awarded to Dompe U.S. Inc., a foreign-owned, for-profit pharmaceutical manufacturer, through the GSA Pharmaceuticals and Drugs schedule (FSS-61-IB). The firm fixed-price delivery order has a ceiling value of $38,614.40 and an ultimate completion date of November 29, 2024. This award is not associated with a set-aside designation. Dompe U.S. Inc. has received multiple similar delivery orders against this GSA schedule to provide Oxervate to various VA Integrated Service Networks, as well as a $2.4 million blanket purchase agreement and a $5 million FSS schedule contract to supply pharmaceuticals to the VA. These contract vehicles enable the VA to meet the urgent medication needs of veterans across the country.
Quick answers
Who was awarded contract 36C24525N0204?
36C24525N0204 was awarded to Dompe U.s. Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 26, 2024.
How much is contract 36C24525N0204 worth?
The government has obligated $38,614 on 36C24525N0204.
Is contract 36C24525N0204 an order under another contract?
Yes. 36C24525N0204 is a delivery order under 36F79720D0017, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0204 competed?
The extent of competition for 36C24525N0204 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award